UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

CD38 expression in chronic lymphocytic leukemia is regulated by the tumor microenvironment

Blood, 2008-05, Vol.111 (10), p.5173-5181

2008

Volltextzugriff (PDF)

Acquisition of potential N-glycosylation sites in the immunoglobulin variable region by somatic mutation is a distinctive feature of follicular lymphoma

Blood, 2002-04, Vol.99 (7), p.2562-2568

2002

Volltextzugriff (PDF)

Autoimmune Complications of Chronic Lymphocytic Leukemia

Seminars in oncology, 2006-04, Vol.33 (2), p.230-239

Hamblin, Terry J.

2006

Volltextzugriff (PDF)

ZAP-70 expression and prognosis in chronic lymphocytic leukaemia

The Lancet (British edition), 2004-01, Vol.363 (9403), p.105-111

2004

Volltextzugriff (PDF)

CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease

Blood, 2002-02, Vol.99 (3), p.1023-1029

2002

Volltextzugriff (PDF)

ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile

Blood, 2003-06, Vol.101 (12), p.4944-4951

2003

Volltextzugriff (PDF)

B-Cell Chronic Lymphocytic Leukemia: A Bird of a Different Feather

Journal of clinical oncology, 1999-01, Vol.17 (1), p.399-408

1999

Volltextzugriff (PDF)

Searching for surrogates for IGHV mutations in chronic lymphocytic leukemia

Leukemia research, 2011-11, Vol.35 (11), p.1432-1435

Hamblin, Terry J

2011

Volltextzugriff (PDF)

Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors

Blood, 2002-08, Vol.100 (4), p.1177-1184

2002

Volltextzugriff (PDF)

Non-hemic autoimmunity in CLL

Leukemia research, 2009-03, Vol.33 (3), p.366-367

Hamblin, Terry J

2009

Volltextzugriff (PDF)

Myocardial iron loading by magnetic resonance imaging T2 in good prognostic myelodysplastic syndrome patients on long‐term blood transfusions

British journal of haematology, 2007-09, Vol.138 (5), p.587-593

2007

Volltextzugriff (PDF)

Prognostic markers in chronic lympocytic leukaemia

Best practice & research. Clinical haematology, 2007-09, Vol.20 (3), p.455-468

Hamblin, Terry J., DM, FRCP, FRCPath, FmedSci

2007

Volltextzugriff (PDF)

Just exactly how common is CLL?

Leukemia research, 2009-11, Vol.33 (11), p.1452-1453

Hamblin, Terry J

2009

Volltextzugriff (PDF)

The TCL1 mouse as a model for chronic lymphocytic leukemia

Leukemia research, 2010-02, Vol.34 (2), p.135-136

Hamblin, Terry J

2010

Volltextzugriff (PDF)

Have we been wrong about ionizing radiation and chronic lymphocytic leukemia?

Leukemia research, 2008-04, Vol.32 (4), p.523-525

Hamblin, Terry J

2008

Volltextzugriff (PDF)

Fludarabine, cyclophosphamide and rituximab for chronic lymphocytic leukemia: no country for old men?

Nature clinical practice. Oncology, 2009-03, Vol.6 (3), p.130-131

Hamblin, Terry J

2009

Volltextzugriff (PDF)

Ligandless receptors find a role

Blood, 2008-07, Vol.112 (1), p.2-3

Hamblin, Terry J.

2008

Volltextzugriff (PDF)

Determination of how many immunoglobulin variable region heavy chain mutations are allowable in unmutated chronic lymphocytic leukaemia – long‐term follow up of patients with different percentages of mutations

British journal of haematology, 2008-02, Vol.140 (3), p.320-323

2008

Volltextzugriff (PDF)

Predicting Progression — ZAP-70 in CLL

The New England journal of medicine, 2004-08, Vol.351 (9), p.856-857

Hamblin, Terry J

2004

Volltextzugriff (PDF)

Disappointments in Treating Acute Leukemia in the Elderly

The New England journal of medicine, 1995-06, Vol.332 (25), p.1712-1714

Hamblin, Terry J

1995

Volltextzugriff (PDF)

DNA vaccines with single-chain Fv fused to fragment C of tetanus toxin induce protective immunity against lymphoma and myeloma

Nature medicine, 1998-11, Vol.4 (11), p.1281-1286

1998

Volltextzugriff (PDF)

Long-lasting response of therapy-resistant viral warts to treatment with interleukin-2 in a patient with chronic lymphocytic leukemia (CLL) and profound immunodeficiency

Leukemia research, 2007-03, Vol.31 (3), p.413-414

Hamblin, Terry J

2007

Volltextzugriff (PDF)

ZAP-70 levels do change in CLL but not very often

Leukemia & lymphoma, 2007-01, Vol.48 (6), p.1059-1060

Hamblin, Terry J.

2007

Volltextzugriff (PDF)

Typical Waldenstrom macroglobulinemia is derived from a B-cell arrested after cessation of somatic mutation but prior to isotype switch events

Blood, 2002-08, Vol.100 (4), p.1505-1507

2002

Volltextzugriff (PDF)

1 – 25 von 109

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(103)
Mit Volltextzugriff
(92)

Publikationsform

Sprache

Englisch
(109)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(66)
Science & Technology
(66)
Humans
(65)
Hematology
(37)
Biological And Medical Sciences
(30)
Medical Sciences
(28)
Oncology
(24)
Immunoglobulin Variable Region - Genetics
(23)
Hematologic And Hematopoietic Diseases
(21)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(21)
Male
(18)
Immunoglobulin Heavy Chains - Genetics
(17)
Leukemia, Lymphocytic, Chronic, B-Cell - Genetics
(17)
Aged
(16)
Prognosis
(16)
Molecular Sequence Data
(14)
Mutation
(14)
Female
(13)
Genes, Immunoglobulin
(13)
Middle Aged
(13)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Alemtuzumab in Combination With Methylprednisolone Is a Highly Effective Induction Regimen for Patients With Chronic Lymphocytic Leukemia and Deletion of TP53: Final Results of the National Cancer Research Institute CLL206 Trial

CD38 expression in chronic lymphocytic leukemia is regulated by the tumor microenvironment

Acquisition of potential N-glycosylation sites in the immunoglobulin variable region by somatic mutation is a distinctive feature of follicular lymphoma

Autoimmune Complications of Chronic Lymphocytic Leukemia

ZAP-70 expression and prognosis in chronic lymphocytic leukaemia

CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease

ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile

B-Cell Chronic Lymphocytic Leukemia: A Bird of a Different Feather

Searching for surrogates for IGHV mutations in chronic lymphocytic leukemia

Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors

Non-hemic autoimmunity in CLL

Myocardial iron loading by magnetic resonance imaging T2 in good prognostic myelodysplastic syndrome patients on long‐term blood transfusions

Prognostic markers in chronic lympocytic leukaemia

Just exactly how common is CLL?

The TCL1 mouse as a model for chronic lymphocytic leukemia

Have we been wrong about ionizing radiation and chronic lymphocytic leukemia?

Fludarabine, cyclophosphamide and rituximab for chronic lymphocytic leukemia: no country for old men?

Ligandless receptors find a role

Determination of how many immunoglobulin variable region heavy chain mutations are allowable in unmutated chronic lymphocytic leukaemia – long‐term follow up of patients with different percentages of mutations

Predicting Progression — ZAP-70 in CLL

Disappointments in Treating Acute Leukemia in the Elderly

DNA vaccines with single-chain Fv fused to fragment C of tetanus toxin induce protective immunity against lymphoma and myeloma

Long-lasting response of therapy-resistant viral warts to treatment with interleukin-2 in a patient with chronic lymphocytic leukemia (CLL) and profound immunodeficiency

ZAP-70 levels do change in CLL but not very often

Typical Waldenstrom macroglobulinemia is derived from a B-cell arrested after cessation of somatic mutation but prior to isotype switch events

Suchergebnisse filtern